iMAgery Focused Therapy for PSychosis (iMAPS-2): An Assessor-blind Feasibility Randomized Controlled Clinical Trial.

Taylor CDJ, Helliwell B, Coleman R, Sutton CJ, Hutton P, Sylvestre Y, Bird L, Shields G, Kelly JA, Brandwood-Spencer T, Boland A, Sharrock-Ingham E, Babatunde B, Beech A, Vikram A, Guillemard S, Arntz A, Harper SF, Berry K

Open source

DOI
10.1093/schbul/sbaf060
Published
2025 Oct 6
Container
Schizophrenia bulletin
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/schbul/sbaf060,
  title = {iMAgery Focused Therapy for PSychosis (iMAPS-2): An Assessor-blind Feasibility Randomized Controlled Clinical Trial.},
  author = {Taylor CDJ and Helliwell B and Coleman R and Sutton CJ and Hutton P and Sylvestre Y and Bird L and Shields G and Kelly JA and Brandwood-Spencer T and Boland A and Sharrock-Ingham E and Babatunde B and Beech A and Vikram A and Guillemard S and Arntz A and Harper SF and Berry K},
  year = {2025},
  journal = {Schizophrenia bulletin},
  doi = {10.1093/schbul/sbaf060},
  url = {https://doi.org/10.1093/schbul/sbaf060}
}

RIS

TY  - JOUR
TI  - iMAgery Focused Therapy for PSychosis (iMAPS-2): An Assessor-blind Feasibility Randomized Controlled Clinical Trial.
AU  - Taylor CDJ
AU  - Helliwell B
AU  - Coleman R
AU  - Sutton CJ
AU  - Hutton P
AU  - Sylvestre Y
AU  - Bird L
AU  - Shields G
AU  - Kelly JA
AU  - Brandwood-Spencer T
AU  - Boland A
AU  - Sharrock-Ingham E
AU  - Babatunde B
AU  - Beech A
AU  - Vikram A
AU  - Guillemard S
AU  - Arntz A
AU  - Harper SF
AU  - Berry K
PY  - 2025
JO  - Schizophrenia bulletin
DO  - 10.1093/schbul/sbaf060
UR  - https://doi.org/10.1093/schbul/sbaf060
ER  - 

APA

CDJ, T., B, H., R, C., CJ, S., P, H., Y, S., L, B., G, S., JA, K., T, B., A, B., E, S., B, B., A, B., A, V., S, G., A, A., SF, H., & K, B. (2025). iMAgery Focused Therapy for PSychosis (iMAPS-2): An Assessor-blind Feasibility Randomized Controlled Clinical Trial.. Schizophrenia bulletin. https://doi.org/10.1093/schbul/sbaf060

Source records